Physical Activity Program for Breast and Colon Cancer Survivors

N/A

Recruiting

Led By Shirley Bluethmann

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if using a physical activity index screener, exercise coaching, and self-monitoring can help breast or colon cancer patients increase physical activity and reduce time spent sitting or being inactive."

Who is the study for?

This trial is for breast and colon cancer survivors who are interested in increasing their physical activity. Participants should be willing to use educational materials, wear an activity tracker, complete health surveys, and possibly receive exercise coaching calls.

What is being tested?

The study tests if a Physical Activity Index screener combined with exercise coaching and self-monitoring can help survivors of breast or colon cancer become more active and spend less time sitting.

What are the potential side effects?

Since this trial focuses on physical activity, side effects may include typical exercise-related issues such as muscle soreness or fatigue. However, these activities are generally safe and beneficial for most people.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of Eligible Participants - Participation Rate

Number of Participants Who Complete Study Questionnaires - Retention

Percentage of Participants to Complete Exercise Sessions - Adherence

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Patient Intervention ArmExperimental Treatment7 Interventions

Participants randomized into the intervention arm will receive a pre-exercise screening call about two weeks after enrolling into the study and complete the six (6) study visits and pre-determined test and procedures for the patient intervention arm.

Group II: Waitlist Control ArmActive Control6 Interventions

Participants randomized to the waitlist control arm, will have vitals collected and complete surveys at the first (baseline), 3-month, and 6-month visits pre-determined test and procedures for the waitlist control arm. The pre-exercise consultation will begin after the 6-month visit.

Do I qualify?Apply below to find out